OUR PRODUCTS

MOBILE APPS

GENERAL INFO

YMAB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Y-mAbs Therapeutics (YMAB) Earnings Date & Reports

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

YMAB is expected to report earnings to rise 218.57% to -22 cents per share on November 06

Y-mAbs Therapeutics YMAB Stock Earnings Reports

Q3'25

Est.

$-0.22

Q2'25

Beat

by $0.19

Q1'25

Beat

by $0.07

Q4'24

Missed

by $0.03

Q3'24

Missed

by $0.01

The last earnings report on August 08 showed earnings per share of -7 cents, beating the estimate of -25 cents. With 1.10M shares outstanding, the current market capitalization sits at 387.14M.

View a ticker or compare two or three

Compare

YMAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For YMAB
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. YMAB showed earnings on August 08, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of novel antibody therapeutics for oncology targets

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

230 Park Avenue

Phone

+1 646 885-8505

Employees

100

Web

https://www.ymabs.com